Viemed Healthcare (VMD) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $0.09.
- Viemed Healthcare's EPS (Weighted Average and Diluted) fell 1000.0% to $0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.34, marking a year-over-year increase of 3076.92%. This contributed to the annual value of $0.28 for FY2024, which is 1183.9% up from last year.
- Latest data reveals that Viemed Healthcare reported EPS (Weighted Average and Diluted) of $0.09 as of Q3 2025, which was down 1000.0% from $0.08 recorded in Q2 2025.
- Viemed Healthcare's 5-year EPS (Weighted Average and Diluted) high stood at $0.11 for Q4 2024, and its period low was $0.02 during Q2 2022.
- For the 5-year period, Viemed Healthcare's EPS (Weighted Average and Diluted) averaged around $0.06, with its median value being $0.06 (2023).
- As far as peak fluctuations go, Viemed Healthcare's EPS (Weighted Average and Diluted) plummeted by 9166.67% in 2021, and later soared by 20000.0% in 2023.
- Quarter analysis of 5 years shows Viemed Healthcare's EPS (Weighted Average and Diluted) stood at $0.1 in 2021, then dropped by 30.0% to $0.07 in 2022, then grew by 14.29% to $0.08 in 2023, then soared by 35.52% to $0.11 in 2024, then fell by 16.99% to $0.09 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.09 for Q3 2025, versus $0.08 for Q2 2025 and $0.06 for Q1 2025.